Global Ibuprofen Active Pharmaceutical Ingredient (API) Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	156 Pages	TechNavio	July, 2024	INF19115322

Best Price Guarantee
Price	from $2,500
Length	156 Pages
Publisher	TechNavio
Published Date	July, 2024
SKU	INF19115322

Global Ibuprofen Active Pharmaceutical Ingredient (API) Market 2024-2028

Global Ibuprofen Active Pharmaceutical Ingredient (API) Market 2024-2028

The ibuprofen active pharmaceutical ingredient (API) market is forecasted to grow by USD 26.3 mn during 2023-2028, accelerating at a CAGR of 2.08% during the forecast period. The report on the ibuprofen active pharmaceutical ingredient (API) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing geriatric population, evolving API manufacturing scenario in developing countries, and increase in pharmaceutical and biopharmaceutical production.

Technavio's ibuprofen active pharmaceutical ingredient (API) market is segmented as below:

By End-user
Pharmaceutical companies
Contract manufacturing organizations
By Product
Prescription
Over-the-counter
By Geographical Landscape
Asia
North America
Europe
Rest of World (ROW)

This study identifies the paradigm shift in API manufacturing as one of the prime reasons driving the ibuprofen active pharmaceutical ingredient (API) market growth during the next few years. Also, increase in r and d investments by ibuprofen API manufacturers and increase number of CEP approval for manufacture of ibuprofen API will lead to sizable demand in the market.

The report on the ibuprofen active pharmaceutical ingredient (API) market covers the following areas:

Ibuprofen active pharmaceutical ingredient (API) market sizing
Ibuprofen active pharmaceutical ingredient (API) market forecast
Ibuprofen active pharmaceutical ingredient (API) market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ibuprofen active pharmaceutical ingredient (API) market vendors that include Arch Pharmalabs Ltd., Athos Chemicals Pvt. Ltd., Azelis SA, BASF SE, Chemino Pharma Ltd., DR Reddys Laboratories Ltd., Granules India Ltd., HELM AG, IOL Chemicals and Pharmaceuticals Ltd., Mallinckrodt PLC, Octavius Pharma Pvt. Ltd., Otto Brandes GmbH, Piramal Enterprises Ltd., Rochem International Inc., SI Group Inc., Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd., Solara Active Pharma Sciences Ltd, Strides Pharma Science Ltd., Teva Pharmaceutical Industries Ltd., and Titan LAB Pvt Ltd.. Also, the ibuprofen active pharmaceutical ingredient (API) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Ibuprofen Active Pharmaceutical Ingredient (API) Market 2018 - 2022; Historic Market Size - Data Table on Global Ibuprofen Active Pharmaceutical Ingredient (API) Market 2018 - 2022 ($ million); 4.2 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.3 Product segment analysis 2018 - 2022; Historic Market Size - Product Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 6.3 Pharmaceutical companies - Market size and forecast 2023-2028; Chart on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million); Data Table on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million); Chart on Pharmaceutical companies - Year-over-year growth 2023-2028 (%); Data Table on Pharmaceutical companies - Year-over-year growth 2023-2028 (%); 6.4 Contract manufacturing organizations - Market size and forecast 2023-2028; Chart on Contract manufacturing organizations - Market size and forecast 2023-2028 ($ million); Data Table on Contract manufacturing organizations - Market size and forecast 2023-2028 ($ million); Chart on Contract manufacturing organizations - Year-over-year growth 2023-2028 (%); Data Table on Contract manufacturing organizations - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Product: 7.1 Market segments; Chart on Product - Market share 2023-2028 (%); Data Table on Product - Market share 2023-2028 (%); 7.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 7.3 Prescription - Market size and forecast 2023-2028; Chart on Prescription - Market size and forecast 2023-2028 ($ million); Data Table on Prescription - Market size and forecast 2023-2028 ($ million); Chart on Prescription - Year-over-year growth 2023-2028 (%); Data Table on Prescription - Year-over-year growth 2023-2028 (%); 7.4 Over-the-counter - Market size and forecast 2023-2028; Chart on Over-the-counter - Market size and forecast 2023-2028 ($ million); Data Table on Over-the-counter - Market size and forecast 2023-2028 ($ million); Chart on Over-the-counter - Year-over-year growth 2023-2028 (%); Data Table on Over-the-counter - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.4 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.5 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 India - Market size and forecast 2023-2028; Chart on India - Market size and forecast 2023-2028 ($ million); Data Table on India - Market size and forecast 2023-2028 ($ million); Chart on India - Year-over-year growth 2023-2028 (%); Data Table on India - Year-over-year growth 2023-2028 (%); 9.9 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.10 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.11 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Athos Chemicals Pvt. Ltd.; Athos Chemicals Pvt. Ltd. - Overview; Athos Chemicals Pvt. Ltd. - Product / Service; Athos Chemicals Pvt. Ltd. - Key offerings; 12.4 Azelis SA; Azelis SA - Overview; Azelis SA - Business segments; Azelis SA - Key offerings; Azelis SA - Segment focus; 12.5 BASF SE; BASF SE - Overview; BASF SE - Business segments; BASF SE - Key news; BASF SE - Key offerings; BASF SE - Segment focus; 12.6 Chemino Pharma Ltd.; Chemino Pharma Ltd. - Overview; Chemino Pharma Ltd. - Product / Service; Chemino Pharma Ltd. - Key offerings; 12.7 Dr Reddys Laboratories Ltd.; Dr Reddys Laboratories Ltd. - Overview; Dr Reddys Laboratories Ltd. - Business segments; Dr Reddys Laboratories Ltd. - Key news; Dr Reddys Laboratories Ltd. - Key offerings; Dr Reddys Laboratories Ltd. - Segment focus; 12.8 Granules India Ltd.; Granules India Ltd. - Overview; Granules India Ltd. - Product / Service; Granules India Ltd. - Key news; Granules India Ltd. - Key offerings; 12.9 IOL Chemicals and Pharmaceuticals Ltd.; IOL Chemicals and Pharmaceuticals Ltd. - Overview; IOL Chemicals and Pharmaceuticals Ltd. - Business segments; IOL Chemicals and Pharmaceuticals Ltd. - Key offerings; IOL Chemicals and Pharmaceuticals Ltd. - Segment focus; 12.10 Octavius Pharma Pvt. Ltd.; Octavius Pharma Pvt. Ltd. - Overview; Octavius Pharma Pvt. Ltd. - Product / Service; Octavius Pharma Pvt. Ltd. - Key offerings; 12.11 Piramal Enterprises Ltd.; Piramal Enterprises Ltd. - Overview; Piramal Enterprises Ltd. - Product / Service; Piramal Enterprises Ltd. - Key offerings; 12.12 Rochem International Inc.; Rochem International Inc. - Overview; Rochem International Inc. - Product / Service; Rochem International Inc. - Key offerings; 12.13 SI Group Inc.; SI Group Inc. - Overview; SI Group Inc. - Product / Service; SI Group Inc. - Key offerings; 12.14 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd.; Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Overview; Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Product / Service; Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Key offerings; 12.15 Solara Active Pharma Sciences Ltd; Solara Active Pharma Sciences Ltd - Overview; Solara Active Pharma Sciences Ltd - Product / Service; Solara Active Pharma Sciences Ltd - Key offerings; 12.16 Strides Pharma Science Ltd.; Strides Pharma Science Ltd. - Overview; Strides Pharma Science Ltd. - Product / Service; Strides Pharma Science Ltd. - Key offerings; 12.17 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations; Exhibits:; Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Product; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Ibuprofen Active Pharmaceutical Ingredient (API) Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on End-user - Market share 2023-2028 (%); Exhibits33: Data Table on End-user - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by End-user; Exhibits35: Data Table on Comparison by End-user; Exhibits36: Chart on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Contract manufacturing organizations - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Contract manufacturing organizations - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Contract manufacturing organizations - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Contract manufacturing organizations - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by End-user ($ million); Exhibits45: Data Table on Market opportunity by End-user ($ million); Exhibits46: Chart on Product - Market share 2023-2028 (%); Exhibits47: Data Table on Product - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by Product; Exhibits49: Data Table on Comparison by Product; Exhibits50: Chart on Prescription - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on Prescription - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on Prescription - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on Prescription - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Over-the-counter - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Over-the-counter - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Over-the-counter - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Over-the-counter - Year-over-year growth 2023-2028 (%); Exhibits58: Market opportunity by Product ($ million); Exhibits59: Data Table on Market opportunity by Product ($ million); Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits63: Chart on Geographic comparison; Exhibits64: Data Table on Geographic comparison; Exhibits65: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits66: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits67: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits68: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on India - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on India - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on India - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on India - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits101: Market opportunity By Geographical Landscape ($ million); Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits103: Impact of drivers and challenges in 2023 and 2028; Exhibits104: Overview on criticality of inputs and factors of differentiation; Exhibits105: Overview on factors of disruption; Exhibits106: Impact of key risks on business; Exhibits107: Companies covered; Exhibits108: Matrix on companies position and classification; Exhibits109: Athos Chemicals Pvt. Ltd. - Overview; Exhibits110: Athos Chemicals Pvt. Ltd. - Product / Service; Exhibits111: Athos Chemicals Pvt. Ltd. - Key offerings; Exhibits112: Azelis SA - Overview; Exhibits113: Azelis SA - Business segments; Exhibits114: Azelis SA - Key offerings; Exhibits115: Azelis SA - Segment focus; Exhibits116: BASF SE - Overview; Exhibits117: BASF SE - Business segments; Exhibits118: BASF SE - Key news; Exhibits119: BASF SE - Key offerings; Exhibits120: BASF SE - Segment focus; Exhibits121: Chemino Pharma Ltd. - Overview; Exhibits122: Chemino Pharma Ltd. - Product / Service; Exhibits123: Chemino Pharma Ltd. - Key offerings; Exhibits124: Dr Reddys Laboratories Ltd. - Overview; Exhibits125: Dr Reddys Laboratories Ltd. - Business segments; Exhibits126: Dr Reddys Laboratories Ltd. - Key news; Exhibits127: Dr Reddys Laboratories Ltd. - Key offerings; Exhibits128: Dr Reddys Laboratories Ltd. - Segment focus; Exhibits129: Granules India Ltd. - Overview; Exhibits130: Granules India Ltd. - Product / Service; Exhibits131: Granules India Ltd. - Key news; Exhibits132: Granules India Ltd. - Key offerings; Exhibits133: IOL Chemicals and Pharmaceuticals Ltd. - Overview; Exhibits134: IOL Chemicals and Pharmaceuticals Ltd. - Business segments; Exhibits135: IOL Chemicals and Pharmaceuticals Ltd. - Key offerings; Exhibits136: IOL Chemicals and Pharmaceuticals Ltd. - Segment focus; Exhibits137: Octavius Pharma Pvt. Ltd. - Overview; Exhibits138: Octavius Pharma Pvt. Ltd. - Product / Service; Exhibits139: Octavius Pharma Pvt. Ltd. - Key offerings; Exhibits140: Piramal Enterprises Ltd. - Overview; Exhibits141: Piramal Enterprises Ltd. - Product / Service; Exhibits142: Piramal Enterprises Ltd. - Key offerings; Exhibits143: Rochem International Inc. - Overview; Exhibits144: Rochem International Inc. - Product / Service; Exhibits145: Rochem International Inc. - Key offerings; Exhibits146: SI Group Inc. - Overview; Exhibits147: SI Group Inc. - Product / Service; Exhibits148: SI Group Inc. - Key offerings; Exhibits149: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Overview; Exhibits150: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Product / Service; Exhibits151: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Key offerings; Exhibits152: Solara Active Pharma Sciences Ltd - Overview; Exhibits153: Solara Active Pharma Sciences Ltd - Product / Service; Exhibits154: Solara Active Pharma Sciences Ltd - Key offerings; Exhibits155: Strides Pharma Science Ltd. - Overview; Exhibits156: Strides Pharma Science Ltd. - Product / Service; Exhibits157: Strides Pharma Science Ltd. - Key offerings; Exhibits158: Teva Pharmaceutical Industries Ltd. - Overview; Exhibits159: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibits160: Teva Pharmaceutical Industries Ltd. - Key news; Exhibits161: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibits162: Teva Pharmaceutical Industries Ltd. - Segment focus; Exhibits163: Inclusions checklist; Exhibits164: Exclusions checklist; Exhibits165: Currency conversion rates for US$; Exhibits166: Research methodology; Exhibits167: Information sources; Exhibits168: Data validation; Exhibits169: Validation techniques employed for market sizing; Exhibits170: Data synthesis; Exhibits171: 360 degree market analysis; Exhibits172: List of abbreviations